Collaboration Needed To Ensure Access To Orphan Drugs – Express Scripts Exec
This article was originally published in The Pink Sheet Daily
Executive Summary
In an effort to ensure that there is access to high-priced drugs that treat rare diseases, relevant stakeholders, including manufacturers, payers, patients and physicians, need to come together and collaborate on access solutions that meet the needs of all parties, Express Scripts VP of Pharma Strategies and Account Management Bill Martin tells NORD/DIA conference.